This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
I am excited as the organization moves into our second century and to embrace new and innovative strategies to expand our research and understanding of how we can ensure cardiovascular health and total health for all.” During our second century we will continue to make health equity a priority across the globe.
Taylor's, MD, FACC, pioneering career in cardiovascular medicine has been characterized by a lot of change, but his commitment to improving the health of all patients has remained constant, thanks in part to his grandmother who reminded him early in his career that health is one of life's greatest blessings.
Enrique Caballero, MD , will deliver the keynote speech, Screening for Social Determinants of Cardiometabolic Health and Practice Implications. Dr. Caballero is an endocrinologist, clinical investigator, and faculty director of International Innovation and Diabetes Education at Harvard Medical School. That is not true.”
The Society for Cardiovascular Angiography & Interventions (SCAI) kicks off its SCAI Scientific Sessions 2024 this week, May 2-4 in Long Beach, CA, bringing together more than 1,800 clinicians, scientists, researchers, and innovators in the field of interventional cardiology and endovascular medicine. Sinai Hospital (New York, NY).
Coronary Computed Tomography Angiography Developments At RSNA23, ITN had the opportunity to speak with Bhvita Jani, principal analyst at Signify Research, about advancements and trends in medical imaging, including the development of coronary CTA. Here is a brief overview of several significant developments in computed tomography.
There is increased cognizance of gender inequality and the importance of inclusive and diverse approaches to medical research. Historically, women have been underrepresented in scientific fields, and this spills over into the research and study of women’s health.
We can trace the roots of this misconception back to 1948 with the start of the long-term, ongoing Framingham Heart Study , which wrongly attributed age and sex of heart disease risks to only men in their 30s and 40s, cementing heart disease as a man’s disease and putting gender blinders on further research and treatment.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content